SCINTIMUN® 1 mg
Kit for Labelling Monoclonal Antibody (MAb) BW 250/183 with Technetium (99mTc)

Isotope Technetium (99mTc)
Number of labelling sets 2
Each vial 1 contains 5.02 mg dry substance :
Besilesomab
Disodium hydrogen phosphate, anhydrous
Sodium dihydrogen phosphate, anhydrous
Under nitrogen atmosphere
Sorbitol E420
Each vial 2 contains 3 mg dry substance :
1,1,3,3-propane tetraphosphonic acid, tetrasodium salt, dihydrate (PTP)
Tin (II) chloride dihydrate
Sodium hydroxyde 1N
(pH adjustment)
Hydrochloric acid 1N
(pH adjustment)
Under nitrogen atmosphere


1 mg
1.42 mg

0.60 mg


2 mg



2.7 mg


0.12 mg

 
Volume of pertechnetate 99mTc to use for reconstitution 2 to 7 mL
Radiochemical purity ≥ 95 %
Storage 2 years at 2 - 8°C
Stability of labelled product 3 h at 2-8°C
Protected from light and atmospheric oxygen
Activity per vial 300 to 1800 MBq
Indications / Posology Detection of location of infectious/inflammatory lesions (400-800 MBq)
Bone marrow scintigraphy (200 - 400 MBq)
Time between injection and examination 3 to 6 h and late image 24 h
Availability From stock

Literature for download:


Making bone inflammation/infection simpler to detect

Scintimum product monograph